SenesTech Inc Dossier - Source-backed chat

SenesTech Inc

SNESNASDAQ

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)0.49

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.67Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $3.6M

Enterprise Value −$1.3M

Shares Outstanding 5.3M diluted

Next Earnings Date12 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

SenesTech, Inc. (NASDAQ: SNES) is transitioning from a third-party managed sales model to an in-house, e-commerce-driven direct-to-consumer (DTC) and subscription model under its newly appointed CEO, Michael Edell. While the company has achieved record gross margins (68.6% in Q1 2026) and strong growth in its subscription and B2B channels, it remains a micro-cap company with substantial operating losses ($2.1 million net loss in Q1 2026) relative to its modest revenue base ($493,000 in Q1 2026). The successful execution of its direct Amazon management strategy and the upcoming Q3 2026 e-commerce website redesign are critical to achieving self-sustaining scale before its $6.8 million cash runway is depleted.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets2 analysts · as of 18 Aug 2026

Low · most bearish analyst$3.50

Mean target$6.75

High · most bullish analyst$10.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Top-line growth lags expectations due to slow market adoption of non-lethal rodent contraceptives over traditional rodenticides. High customer acquisition costs and elevated operating expenses deplete the cash runway, forcing highly dilutive equity raises or warrant restructurings.

Base CaseCentral scenario

The company successfully leverages its in-house Amazon management and subscription model to drive steady double-digit DTC growth. B2B municipal and international expansions (such as Bermuda and New Zealand) continue to gain traction, gradually narrowing operating losses while maintaining gross margins above 65%.

Bull CaseUpside scenario

Rapid expansion of high-margin direct-to-consumer (D2C) and subscription channels under new CEO Michael Edell, combined with B2B vertical scaling and municipal pilot programs, driving the company toward cash flow positivity.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Unique proprietary technology as the only manufacturer of EPA-compliant rodent birth control products (ContraPest and Evolve).
Record-high gross margins (68.6% in Q1 2026) driven by a favorable shift toward direct-to-consumer and subscription channels.
Strong early momentum in recurring subscription revenue, which grew 44% in Q1 2026 and showed a 198% year-over-year increase in April 2026.
Expanding international footprint with recent distribution agreements in Bermuda and New Zealand.

Key Investment Risks

Significant ongoing net losses ($2.1 million in Q1 2026) relative to a very small quarterly revenue base ($493,000).
Limited cash runway with $6.8 million in cash and equivalents as of March 31, 2026, down from $10.06 million at the end of Q4 2025.
High market concentration and competition from established, large-scale traditional rodenticide manufacturers (e.g., Neogen, Syngenta, Bayer).
Execution risk associated with the transition to direct management of Amazon sales and the upcoming e-commerce platform redesign.

Thesis Invalidation Triggers

Failure to narrow quarterly net losses or stabilize cash burn over the next two quarters.
A significant drop in DTC or subscription growth rates following the Q3 2026 website redesign.
Inability to secure additional non-dilutive capital or strategic partnerships if cash reserves fall below $3.0 million.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.